Evocutis (trading assets) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 1

Evocutis (trading assets) General Information

Description

Portfolio of skin-care products. The portfolio includes contract research assays associated with Labskin, plus in vitro skin models, skin microbiology expertise and clinical trial support services focused entirely on dermatology.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Biotechnology
Acquirer
Venn Life Sciences
Primary Office
  • Suite 3B, 38 Jermyn Street
  • London SW1Y 6DN
  • England, United Kingdom
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Evocutis (trading assets) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Evocutis (trading assets)‘s full profile, request access.

Request a free trial

Evocutis (trading assets) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Evocutis (trading assets)‘s full profile, request access.

Request a free trial